Giant Biogene Holding (HKG:2367) is targeting to raise HK$2.33 billion through a top-up placement, according to a Thursday disclosure.
Juzi Holding, the firm's controlling shareholder, is selling its 35 million shares in the company at HK$66.65 apiece.
The manufacturer of professional skin treatment products will then issue new shares to Juzi Holding, which agreed to subscribe for the exact number of shares it sold at the same price.
Upon completion of the deals, Juzi's stake in Giant Biogene will fall to 54.26% from 56.10%.
Deal proceeds will go towards marketing, category expansion, overseas business and research and development, and general corporate purposes.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。